IntroductionThe development of next‐generation sequencing technologies (NGS) has opened new opportunities to better characterize complex eukaryotic cells at the transcriptome level. RNA sequencing (RNA‐Seq) has proven highly accurate and reproducible on expression level measurements and has many advantages over previous technologies such as microarrays. Almost the whole transcriptome can be measured at once and it is not limited to organisms with known genomic sequence. RNA‐Seq provides single‐base resolution for annotation, distinguishing different splice variant forms and single‐nucleotide polymorphisms. It has very low background signal, enabling measurement of low abundant transcripts, and a wide dynamic range as there is no upper‐limit for quantification. Finally, a relatively small amount of total RNA is required compared to microarrays.The comparison of different cell scenarios is a way to extract meaningful information out of “omics” approaches. Thereby, contrasting transcriptomics data from different culture conditions or cell lines can allow finding features related to those specific phenotypes. Chinese Hamster Ovary (CHO) cells are the preferred host for recombinant therapeutic protein production, currently being used for the production of five of the top ten blockbuster drugs. The recombinant protein yield in mammalian cells has increased more than 100‐fold over the past three decades largely through media
Biotechnology Journal – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera